Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 263-336-9 | CAS number: 61931-80-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute oral toxicity in rat (pre-guideline study): LD50 = 2790 mg/kg bw (read-across)
Acute inhalation toxicity in mice (non-guideline study): LC50 > 3.2 mg/L (read-across)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See attached justification
- Reason / purpose for cross-reference:
- read-across source
- Preliminary study:
- Not relevant
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 790 mg/kg bw
- 95% CL:
- 2 440 - 3 180
- Remarks on result:
- other: Slope function 1.3 (95% CI 1.2-1.4)
- Mortality:
- Death time 4-18 hr
- Clinical signs:
- Ataxia soon after treatment
- Body weight:
- No data
- Gross pathology:
- No data
- Other findings:
- Not relevant
- Interpretation of results:
- not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 of Linalool for rats was found to be 2790 mg/kg bodyweight. Based on this LD50 value, the substance is not classified according to Regulation (EC) 1272/2008. This result was used for read-across to ethyllinalyl acetate.
- Executive summary:
The acute oral toxicity of Linalool to rats was investigated. 10 animals per concentration were used, the substance was administered orally via gavage. The LD50 was found to be 2790 mg/kg body weight. This result was used for read-across to ethyllinalyl acetate.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- no data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Publication with limited details on methods, but study seems to be performed under standardized conditions.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Osborne-Mendel
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: no data- Age at study initiation: young adults- Weight at study initiation: no data- Fasting period before study: 18 hours- Water (e.g. ad libitum): animals had access to water at all timesENVIRONMENTAL CONDITIONSNo data
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- No data
- Doses:
- No data
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: The usual observation period was 2 weeks; in a few cases, where no acute toxic signs were seen, the animals were observed for only one week.- Frequency of observations and weighing: Frequency not known, all animals were maintained under close observation for recording toxic signs and time of death. Such observation was continued until animals appeared normal or showed weight gain.
- Statistics:
- LD50's were computed by the method of Litchfield & Wilcoxon (1949).
- Preliminary study:
- Not relevant
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 790 mg/kg bw
- 95% CL:
- 2 440 - 3 180
- Remarks on result:
- other: Slope function 1.3 (95% CI 1.2-1.4)
- Mortality:
- Death time 4-18 hr
- Clinical signs:
- Ataxia soon after treatment
- Body weight:
- No data
- Gross pathology:
- No data
- Other findings:
- Not relevant
- Interpretation of results:
- not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 of Linalool for rats was found to be 2790 mg/kg bodyweight. Based on this LD50 value, the substance is not classified according to Regulation (EC) 1272/2008.
- Executive summary:
The acute oral toxicity of Linalool to rats was investigated. 10 animals per concentration were used, the substance was administered orally via gavage. The LD50 was found to be 2790 mg/kg body weight.
Referenceopen allclose all
Not relevant
Not relevant
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 790 mg/kg bw
- Quality of whole database:
- The selected study is the key study for this endpoint and performed according to methods similar to an OECD guideline. As such, it is considered appropriate to be used as the basis for the chemical safety assessment.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study not conducted according to international guideline, but performed under standardized conditions. No data on whether study was conducted under GLP.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Mice were exposed to linalool in air under standardized conditions, and the effects on motility was determined.
- GLP compliance:
- no
- Test type:
- other: Inhalation study under standardized conditions
- Limit test:
- no
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: no data- Age at study initiation: 6-8 week and 6 months old- Weight at study initiation: 28.5 g- Housing: in groups of 4 on a bedding of wood shavings in polycarbonate cages (Makrolon, type II)- Diet (e.g. ad libitum): standardized pelleted food T 799 (Tagger, Graz, Austria) ad libitum- Water (e.g. ad libitum): ad libitum- Acclimation period: one hour adaptation period was offered to the animals in which no pharmacological treatment occurred.ENVIRONMENTAL CONDITIONS- Temperature (°C): 22 ± 2°C- Humidity (%): 60 ± 10%- Air changes (per hr): 12-15- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Remarks:
- the substance was introduced directly into the cage in which the mice were present
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTIONFor the exposure of the animals to the fragrance compounds a small glass tube with a slit measuring 3 mm in width and 5 cm in length was used. The fragrance compounds were injected through a small hole of the cage wall and the rubber plug of the glass tube. Immediately after placing the mice into the cages and the horizontal fixation of the glass tube a transparent plastic seal was fixed at the cage to form an airtight seal. A pumping-evaporating-system as a part of a spirometer system as described by Kovar et al. was used to supply fresh air and to guarantee a steady air flow.One hour adaptation period was offered to the animals in which no pharmacological treatment occurred. The small glass tube was then filled with 1.5 ml of the respective fragrance material which was constantly released by the slit. A steady concentration by constant drug evaporation from glass tubes throughout the experiment was ensured.TEST ATMOSPHERE- Brief description of analytical method used: The mean air concentration of linaloool in the cage was determined by means of capillary GC and GC/MS as follows: The air stream carrying the fragrance compounds was passed through a layer of activated charcoal which afterwards was eluted with carbon disulfide. After evaporation of the solvent the amount of fragrance compounds remaining in the air was determined by measuring the difference between the original amount of fragrance material in the glass tube and the residual amount in the charcoal. VEHICLENot applicable
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- To calculate the air concentration of the fragrance compounds in the cage to consider the total drug volume, charcoal tubes were used.
- Duration of exposure:
- 90 min
- Concentrations:
- 27 mg of linalool in approximately 8.4 litres of cage air -> approximately 3.2 mg/l
- No. of animals per sex per dose:
- 4 animals, no data on sex distribution
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: no data- Frequency of observations and weighing: no data- Necropsy of survivors performed: no data- Other examinations performed: the motility of the mice was examined.The mice were kept in a light-barrier cage. The light-barrier, 2 cm above the cagefloor, was interrupted due to the motor activity of the animals crossing it and triggered impulses which were evaluated during the experiment.
- Statistics:
- Statistics were calculated using an Atari 1040 personal computer ("WISTAT" scientific statistic-package program). The significance was determined by Student's "t"-test and F-test, the level of significance chosen for p to reject the null hypothesis was < 0.05.
- Preliminary study:
- Not relevant
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 3.2 mg/L air
- Exp. duration:
- 90 min
- Remarks on result:
- other: no deaths after exposure to 27 mg linalool in 8.4 litres of air
- Mortality:
- No data
- Clinical signs:
- other: The exposure led to a decrease in motility of the mice. The observed motility compared to the motility of the untreated control animals was 32%/96% after 30 minutes inhalation, 8%/85% after 60 minutes inhalation and 0%/71% after 90 minutes inhalation for
- Body weight:
- No data
- Gross pathology:
- No data
- Other findings:
- No data
- Interpretation of results:
- other: causes a decrease in motility in mice
- Conclusions:
- Linalool caused a decrease in motility in mice in a 90-minute inhalation study.
- Executive summary:
The influence of linalool on the motility in mice was tested in an inhalation study under standardized conditions. After 30 minutes, 60 minutes and 90 minutes, the motility in the exposed mice was decreased to 32%/96%, 8%/85% and 0%/71% (6 -8 week old mice/6 month old mice) of the motility of untreated control animals. No deaths were reported at the concentration tested (approximately 3.2 mg/l), therefore the LC50 was determined to be >3.2 mg/l.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See attached justification
- Reason / purpose for cross-reference:
- read-across source
- Preliminary study:
- Not relevant
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 3.2 mg/L air
- Exp. duration:
- 90 min
- Remarks on result:
- other: no deaths after exposure to 27 mg linalool in 8.4 litres of air
- Mortality:
- No data
- Clinical signs:
- other: The exposure led to a decrease in motility of the mice. The observed motility compared to the motility of the untreated control animals was 32%/96% after 30 minutes inhalation, 8%/85% after 60 minutes inhalation and 0%/71% after 90 minutes inhalation for
- Body weight:
- No data
- Gross pathology:
- No data
- Other findings:
- No data
- Interpretation of results:
- other: causes a decrease in motility in mice
- Conclusions:
- Linalool caused a decrease in motility in mice in a 90-minute inhalation study. This result was used for read-across to ethyllinalyl acetate.
- Executive summary:
The influence of linalool on the motility in mice was tested in an inhalation study under standardized conditions. After 30 minutes, 60 minutes and 90 minutes, the motility in the exposed mice was decreased to 32%/96%, 8%/85% and 0%/71% (6 -8 week old mice/6 month old mice) of the motility of untreated control animals. No deaths were reported at the concentration tested (approximately 3.2 mg/l), therefore the LC50 was determined to be >3.2 mg/l. This result was used for read-across to ethyllinalyl acetate.
Referenceopen allclose all
The concentration of linalool in the blood samples following inhalation was approximately 1, 2.8 and 3 ng/ml after 30 minutes, 60 minutes and 90 minutes of exposure, respectively.
The concentration of linalool in the blood samples following inhalation was approximately 1, 2.8 and 3 ng/ml after 30 minutes, 60 minutes and 90 minutes of exposure, respectively.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 3 200 mg/m³
- Quality of whole database:
- The study was not conducted according to international guidelines, but performed under standardized conditions and it is considered appropriate to be used as the basis for the chemical safety assessment.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
The key study was read-across from the substance linalool. An acute toxicity study in rats was performed according to methods similar to OECD 401. Five rats/sex/dose were exposed to linalool by oral gavage. Animals were observed for 14 days. LD50's were computed by the method of Litchfield & Wilcoxon (1949). The LD50 was found to be 2790 mg/kg body weight, which is the most critical LD50 of the four available studies for this endpoint.
In addition, three supporting studies in mice are available of which one was based on read across. The first supporting study was performed with ethyllinalyl acetate and is a pre-guideline study in which 10 CF-1 mice per dose were orally exposed. The animals were observed for 72 hours for mortality. Under the conditions of the test, the LD50 was calculated to be 17974 ± 7568 mg/kg. The second study is a pre-guideline study (Colaianni, 1967) 5 male CFW mice per dose were orally exposed to ethyllinalyl acetate. The animals were observed for 72 hours for mortality. LD50 was calculated by the method of Miller and Tainter and determined to be 8522.0 ± 359 mg/kg bw. The third supporting study was a pre-guideline study performed with Ethyllinalool. 5 male CFW mice per dose were orally exposed to Ethyllinalool. The animals were observed for 72 hours for mortality. LD50 was calculated by the method of Miller and Tainter. Under the conditions of the test, the LD50 was calculated to be 5283 +/- 383 mg/kg bw. This result was read-across to ethyllinalyl acetate.
Acute inhalation toxicity
Two studies are available for this endpoint, both for the read-across substance linalool. The key study is a non-guideline study in which the influence of linalool on the motility in mice was tested after inhalation of vapour under standardized conditions. After 30 minutes, 60 minutes and 90 minutes, the motility in the exposed mice was decreased to 32%/96%, 8%/85% and 0%/71% (6 -8 week old mice/6 month old mice) of the motility of untreated control animals. No deaths were reported at the concentration tested (approximately 3.2 mg/L), therefore the LC50 was determined to be >3.2 mg/L. This result is used for read-across to ethyllinalyl acetate.
The supporting study was a non-guideline study in which the influence of linalool on the motility in mice was tested after inhalation under standardized conditions. After a 1-hour inhalation period, the motility in the exposed mice was decreased by 73% compared to the motility of untreated control animals. No deaths were reported at the dose tested (20-50 mg linalool).
Justification for classification or non-classification
Based on the available information, the test substance does not need to be classified for acute toxicity in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
